EMILY WILLIS: Open Payments
NPI 1457006686 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 8 payments from 6 companies in 2025. Trend: 2023 $284 · 2024 $391 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $45 |
| Biogen, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, LEQEMBI, REXULTI, Kerendia, JARDIANCE, EVENITY.
Industry payments across AL — which companies pay providers there.
